Medicine access options

View as Grid List

Items 109-120 of 401

Set Descending Direction
  1. Nubeqa
    Nubeqa (darolutamide)
    Prostate Cancer
    €4,349.61
  2. Inrebic
    Inrebic (fedratinib)
    Myelofibrosis
    €6,398.86
  3. Talzenna
    Talzenna (talazoparib)
    Breast Cancer
    €6,635.88
  4. Stivarga
    Stivarga (regorafenib)
    Colorectal Cancer
    €3,965.00
  5. Exondys 51
    Exondys 51 (eteplirsen)
    Duchenne Muscular Dystrophy
    €18,348.00
  6. Kadcyla
    Kadcyla (trastuzumab emtansine)
    Breast Cancer
    €3,444.22
  7. Qinlock
    Qinlock (ripretinib)
    Gastric Cancer
    €27,855.28
  8. Tazverik
    Tazverik (tazemetostat)
    Soft Tissue Sarcoma
    €34,652.80
0